190 related articles for article (PubMed ID: 36354350)
1. The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease.
Zhong J; Wu D; Zeng Y; Wu G; Zheng N; Huang W; Li Y; Tao X; Zhu W; Sheng L; Shen X; Zhang W; Zhu R; Li H
Microbiol Spectr; 2022 Dec; 10(6):e0246722. PubMed ID: 36354350
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota dysbiosis in stable coronary artery disease combined with type 2 diabetes mellitus influences cardiovascular prognosis.
Tian R; Liu H; Feng S; Wang H; Wang Y; Wang Y; Liang L; Xu H; Xing H; Zhang S
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1454-1466. PubMed ID: 33810955
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction patients different from stable coronary artery disease.
Dong C; Yang Y; Wang Y; Hu X; Wang Q; Gao F; Sun S; Liu Q; Li L; Liu J; Tang Y; Zhang S; Wu C; Zhu H
J Adv Res; 2023 Apr; 46():101-112. PubMed ID: 35750287
[TBL] [Abstract][Full Text] [Related]
5. Altered Fecal Microbiome and Correlations of the Metabolome with Plasma Metabolites in Dairy Cows with Left Displaced Abomasum.
Luo Z; Yong K; Luo Q; Du Z; Ma L; Huang Y; Zhou T; Yao X; Shen L; Yu S; Deng J; Ren Z; Zhang Y; Yan Z; Zuo Z; Cao S
Microbiol Spectr; 2022 Dec; 10(6):e0197222. PubMed ID: 36222683
[TBL] [Abstract][Full Text] [Related]
6. Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes.
Hu X; Zhou R; Li H; Zhao X; Sun Y; Fan Y; Zhang S
Front Cardiovasc Med; 2021; 8():805812. PubMed ID: 35047580
[No Abstract] [Full Text] [Related]
7. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
8. Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes.
Sun B; Ma T; Li Y; Yang N; Li B; Zhou X; Guo S; Zhang S; Kwok LY; Sun Z; Zhang H
mSystems; 2022 Apr; 7(2):e0010022. PubMed ID: 35343796
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiome across the cardiovascular risk spectrum.
Prins FM; Collij V; Groot HE; Björk JR; Swarte JC; Andreu-Sánchez S; Jansen BH; Fu J; Harmsen HJM; Zhernakova A; Lipsic E; van der Harst P; Weersma RK; Gacesa R
Eur J Prev Cardiol; 2024 Jun; 31(8):935-944. PubMed ID: 38060843
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
[TBL] [Abstract][Full Text] [Related]
11. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
12. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease.
Heinken A; Ravcheev DA; Baldini F; Heirendt L; Fleming RMT; Thiele I
Microbiome; 2019 May; 7(1):75. PubMed ID: 31092280
[TBL] [Abstract][Full Text] [Related]
13. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches.
Dhakan DB; Maji A; Sharma AK; Saxena R; Pulikkan J; Grace T; Gomez A; Scaria J; Amato KR; Sharma VK
Gigascience; 2019 Mar; 8(3):. PubMed ID: 30698687
[TBL] [Abstract][Full Text] [Related]
14. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
Kummen M; Thingholm LB; Rühlemann MC; Holm K; Hansen SH; Moitinho-Silva L; Liwinski T; Zenouzi R; Storm-Larsen C; Midttun Ø; McCann A; Ueland PM; Høivik ML; Vesterhus M; Trøseid M; Laudes M; Lieb W; Karlsen TH; Bang C; Schramm C; Franke A; Hov JR
Gastroenterology; 2021 Apr; 160(5):1784-1798.e0. PubMed ID: 33387530
[TBL] [Abstract][Full Text] [Related]
15. Alterations of host-gut microbiome interactions in multiple sclerosis.
Cantoni C; Lin Q; Dorsett Y; Ghezzi L; Liu Z; Pan Y; Chen K; Han Y; Li Z; Xiao H; Gormley M; Liu Y; Bokoliya S; Panier H; Suther C; Evans E; Deng L; Locca A; Mikesell R; Obert K; Newland P; Wu Y; Salter A; Cross AH; Tarr PI; Lovett-Racke A; Piccio L; Zhou Y
EBioMedicine; 2022 Feb; 76():103798. PubMed ID: 35094961
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiome and Serum Metabolome Analyses Identify Unsaturated Fatty Acids and Butanoate Metabolism Induced by Gut Microbiota in Patients With Chronic Spontaneous Urticaria.
Wang D; Guo S; He H; Gong L; Cui H
Front Cell Infect Microbiol; 2020; 10():24. PubMed ID: 32154184
[TBL] [Abstract][Full Text] [Related]
17. Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis.
Qiu Q; Deng J; Deng H; Yao D; Yan Y; Ye S; Shang X; Deng Y; Han L; Zheng G; Roy B; Chen Y; Han L; Huang R; Fang X; Lu C
Front Immunol; 2022; 13():937539. PubMed ID: 36159864
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients.
Liu L; Luo F
Front Biosci (Landmark Ed); 2022 Mar; 27(3):100. PubMed ID: 35345332
[TBL] [Abstract][Full Text] [Related]
19. Microbiome-Metabolomics Analysis of the Impacts of
Wang L; Cao L; Chang Y; Fu Y; Wang Y; Zhang K; Zhang S; Zhang L
Microbiol Spectr; 2023 Feb; 11(1):e0217522. PubMed ID: 36533947
[TBL] [Abstract][Full Text] [Related]
20. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
